Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma
Status:
Recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of dose reduced
postoperative radiotherapy combined with Anlotinib for patients of soft tissue sarcoma